Clin2
NCT07485777Possibly a fitNot yet recruiting

Metformin cream vs. standard melasma treatment in women

Melasma (Facial Melasma)Melasma

Part of Skin clinical trials.

This study compares a metformin cream to a standard treatment (Kligman's regimen) for reducing melasma, a common skin condition causing dark patches on the face. It aims to find which treatment is more effective for women with this condition.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
82 people
Ages
35 years to 55 years
Study type
Interventional

Who can take part

  • You are a woman aged 35 to 55 years
  • You have been diagnosed with melasma (dark patches on the face) that has lasted for at least 6 months
  • Your skin type is III, IV, or V on the Fitzpatrick scale (ranges from fair to brown)
  • You have not used any melasma treatment (cream or oral) in the past month
  • You are not pregnant or breastfeeding, and you have no allergies to the study medications or active skin conditions like acne or facial dermatitis

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07495748Not yet recruiting
Comparing two creams for facial melasma

This study compares two creams — metformin and tranexamic acid — to see which works better for melasma (dark patches on the face). If you qualify, you'll use one of the creams and your progress will be checked over time.

Rawalpindi, Punjab Province
NCT07604844Not yet recruiting
Melasma treatment: comparing two skin lightening options

This study compares two treatments for melasma: injecting tranexamic acid into the skin versus applying a mandelic acid facial peel. The goal is to see which one works better at lightening the dark patches on your face.

Abbottabad, KPK
NCT06942390Not yet recruiting· Phase 2
Comparing two creams for treating melasma in women

This study compares two different creams applied to the skin — metformin and ketotifen — to see which works better for treating melasma (dark patches on the face). If you are a woman with melasma, you may be eligible to join and receive one of these creams.

NCT07696806Enrolling by invitation· Phase 4
Needle-assisted treatment for melasma using common skin medications

This trial tests a microneedling technique combined with three topical medications (metformin, tranexamic acid, and a modified Kligman's formula) to treat melasma, a common skin condition causing dark patches. The goal is to see if this approach safely and effectively reduces melasma in eligible women.

Tanta
NCT06845540Recruiting· Phase 1/Phase 2
Metformin pills for melasma in Latin American women

This study tests if taking metformin pills can help treat melasma (dark patches on the skin) in Latin American women. It may be a new option for those whose melasma hasn't improved with other treatments.

San Juan, PR
NCT06780644Not yet recruiting
Comparing two combination creams for treating melasma

This study compares two different combination creams for treating melasma, a common skin condition causing dark patches on the face. One cream includes a mild steroid and the other has a different steroid, both with the same lightening ingredients. The goal is to see which works better and is safer for your skin.

Central Jakarta, DKI Jakarta

Hear when a new Melasma (Facial Melasma) trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.